Life Sciences

European researchers have mapped non-coding RNA molecules as potential therapeutic targets for vascular diseases, a finding that could accelerate development of treatments for heart attacks and strokes. The discovery opens a new class of drug candidates for pharmaceutical companies and may reshape treatment strategies for diseases that remain leading causes of death globally.EN

A comprehensive review reveals that age and sex fundamentally alter how lipids accumulate in the aging brain—changes linked to neurodegeneration. The finding could reshape drug development strategies and personalized medicine approaches for Alzheimer's and Parkinson's, where lipid dysfunction plays a central role.EN

Researchers have identified 25 new cases of TRIO gene mutations linked to developmental disorders, nearly doubling the known patient population. The findings could help clinicians recognize and diagnose these conditions earlier, improving outcomes for affected children and informing genetic counseling for families.EN

Scientists have identified specific microRNAs and long noncoding RNAs that control how blood vessel cells age, opening potential targets for slowing cardiovascular decline. The finding could reshape how companies develop drugs to prevent heart disease—a leading cause of death and massive healthcare costs.EN

A comprehensive review of clinical trials and long-term studies finds that swapping animal protein for plant-based alternatives could reduce cardiovascular disease and type 2 diabetes risk. The finding matters to food companies, insurers, and public health planners betting on protein transition trends.EN

A new review reveals that tailoring treatments to individual patients works well for rare genetic disorders but fails for the 70% of deaths caused by common diseases like heart disease and diabetes. The gap exists because these conditions stem from hundreds of genetic and environmental factors, making them far harder to crack than expected.EN

Researchers have charted how two major protein families interact inside cells—a discovery that could accelerate development of medications for conditions from cancer to heart disease. The findings provide a molecular blueprint that pharmaceutical companies can use to design more effective drugs with fewer side effects.EN

A new analysis of newborn screening during COVID-19 reveals how pandemic disruptions affected early disease detection in infants. The findings highlight critical gaps in essential health services and offer lessons for maintaining diagnostic continuity during future crises—a concern for healthcare systems and policymakers managing public health infrastructure.EN

A new review identifies CTLA-4, a key immune checkpoint protein, as both a prognostic marker and potential therapeutic avenue for blood cancers. The findings could help clinicians better predict patient outcomes and develop new immunotherapy strategies for hematological malignancies, which affect hundreds of thousands globally.EN

A new paper maps strategies to combat antimicrobial resistance and tolerance—a growing threat that kills hundreds of thousands annually and drives up healthcare costs. The findings could help pharmaceutical companies and health systems design more effective treatments as bacteria increasingly outsmart existing antibiotics.EN

A major immunology journal has published a retrospective on Dean D. Metcalfe's career, recognizing decades of foundational work in allergy and immune response research. For biotech and pharmaceutical companies developing immunotherapies and allergy treatments, the piece offers historical context on how current drug development pipelines evolved from his discoveries.EN

A new analysis argues that monkeypox cannot be treated as a temporary crisis but requires ongoing investment in surveillance systems, vaccine stockpiles, and antiviral drugs. For governments and health organizations, the finding underscores that premature complacency risks allowing the virus to re-emerge as a endemic public health problem.EN

Researchers have identified eczematized psoriasis—a frequent but underrecognized form of plaque psoriasis—as a clinical blind spot. The finding suggests dermatologists and primary care physicians may be misdiagnosing or inadequately treating a significant patient population, with implications for treatment protocols and patient outcomes across healthcare systems.EN

A 2020 study on boosting cancer-fighting immune cells using nanoparticles has been formally corrected by its authors. While the full nature of the correction remains undisclosed, the delayed corrigendum raises questions about the robustness of findings in emerging immunotherapy research—relevant for biotech firms and healthcare investors evaluating pipeline candidates.EN

Researchers are launching a major clinical trial testing whether melatonin can improve survival rates for uveal melanoma, a rare but aggressive eye cancer. If successful, the findings could expand treatment options for a disease with limited therapies and offer pharmaceutical companies a potential new market opportunity in oncology.EN

Researchers have identified how coxsackievirus triggers the immune system to attack insulin-producing cells, a finding that could reshape prevention strategies for type 1 diabetes. The discovery opens pathways for vaccines and early interventions that could reduce disease onset in at-risk populations, potentially reshaping treatment economics and patient outcomes.EN

A European review of pediatric Lyme neuroborreliosis reveals the disease can cause serious nervous system complications in children—from facial paralysis to cognitive issues—often missed in initial diagnosis. The findings underscore why clinicians and parents in tick-endemic regions need better awareness tools to catch the infection early, potentially reducing long-term disability and healthcare costs.EN

A new Canadian study confirms that ventriculoperitoneal shunts—surgical tubes that drain excess fluid from the brain—remain the primary treatment for normal pressure hydrocephalus, a treatable cause of dementia-like symptoms in older adults. The finding matters for healthcare systems evaluating neurosurgical capacity and for insurers assessing costs of managing this frequently misdiagnosed condition.EN

Researchers identified how Wig-1 protein orchestrates cancer cell destruction by activating p53 target genes. The finding could unlock new drug strategies for tumors that depend on faulty cell death pathways, a major driver of treatment resistance and relapse.EN

Researchers have identified genetic and immune factors that determine whether children develop severe disease from SARS-CoV-2 and Epstein-Barr virus. The findings could guide better screening and personalized treatment strategies, with implications for vaccine design and clinical risk assessment in pediatric populations.EN

A 25-year study confirms that monitoring aortic diameter can help doctors identify which Turner syndrome patients face imminent risk of life-threatening aortic dissection. The finding could refine clinical guidelines and reduce preventable deaths in this population, with implications for how hospitals structure screening and follow-up protocols.EN

Researchers in Ghana found that clinical assessments of how breast cancers respond to chemotherapy often don't match what pathology labs actually see under the microscope. The discrepancy matters for treatment decisions and survival outcomes, potentially affecting how oncologists worldwide evaluate drug effectiveness in underserved regions.EN

Researchers have shown that fermenting plant proteins with specific microorganisms significantly improves their nutritional quality and generates compounds with health benefits. The findings could reshape how food manufacturers produce plant-based alternatives and help address global protein demand without expanding animal agriculture.EN

Researchers have identified nutritional and hereditary factors driving a reversible heart condition in English Cocker Spaniels, showing that taurine supplementation can restore cardiac function. The findings could reshape breeding practices and pet food formulations while offering insights into how nutrient deficiencies trigger disease across species.EN

Five Nordic nations have launched a coordinated master's program to train genetic counselors, addressing a critical gap in personalized medicine services. The network, backed by regional funding, could serve as a model for cross-border healthcare education and help hospitals meet growing demand for genetic expertise as precision medicine expands.EN